CBX3 promotes epithelial-mesenchymal transition in synovial sarcoma via the SHH signaling pathway
American Journal of Cancer Research · 2026 · 16 (3) · 966-984
DOI: 10.62347/ypdz7241 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Yachao Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone and Soft Tissue Neoplasms and Melanoma, The Affiliated Cancer Hospital of Xinjiang Medical University Urumqi 830011, Xinjiang, Chi…. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
modeling, mice were inoculated with Fuji cells. CBX3 expression was significantly upregulated in human synovial sarcoma tumor specimens compared to control tissues. Clinically, patients with high CBX3 expression exhibited significantly shorter overall survival than those with low expression. In vitro, CBX3 promoted cell proliferation, induced EMT, and suppressed mitochondrial oxidative metabolism. Conversely, siRNA-mediated knockdown of CBX3 (si-CBX3) enhanced mitochondrial oxidative activity. Moreover, CBX3 overexpression inhibited ferroptosis in SS cells, whereas its knockdown (sh-CBX3) promoted both ferroptosis and mitochondrial oxidation - effects consistently observed in both in vitro assays and the mouse xenograft model. Mechanistically, CBX3 activated the Sonic Hedgehog (SHH) signaling pathway. Pharmacological inhibition of SHH signaling abrogated CBX3-mediated suppression of ferroptosis and restoration of mitochondrial oxidation. Furthermore, co-immunoprecipitation assays demonstrated that CBX3 physically interacts with SHH protein and stabilizes it by reducing its polyubiquitination. CBX3 drives EMT and tumor progression in SS by activating the SHH/Gli1 signaling axis. Mechanistically, CBX3 binds directly to and SHH and prevents its ubiquitin-mediated degradation, thereby stabilizing the protein. CBX3-SHH subsequently suppresses mitochondrial oxidative metabolism, which in turn inhibits ferroptosis and facilitates EMT - ultimately promoting SS aggressiveness.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Bone and Soft Tissue Neoplasms and Melanoma, The Affiliated Cancer Hospital of Xinjiang Medical University Urumqi 830011, Xinjiang, China.
Zitieren
APA
Sun, Y., Dai, Z., Du, J., Maihemuti, M., Ji, S., & Jiang, R. (2026). CBX3 promotes epithelial-mesenchymal transition in synovial sarcoma via the SHH signaling pathway. American Journal of Cancer Research, 16(3), 966-984. https://doi.org/10.62347/ypdz7241
Vancouver
Sun Y, Dai Z, Du J, Maihemuti M, Ji S, Jiang R. CBX3 promotes epithelial-mesenchymal transition in synovial sarcoma via the SHH signaling pathway. American Journal of Cancer Research. 2026;16(3):966-984. doi:10.62347/ypdz7241
BibTeX
@article{Sun2026,
author = {Sun, Yachao and Dai, Zhibing and Du, Junwei and Maihemuti, Maierdanjian and Ji, Suzhi and Jiang, Renbing},
title = {CBX3 promotes epithelial-mesenchymal transition in synovial sarcoma via the SHH signaling pathway},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {3},
pages = {966--984},
doi = {10.62347/ypdz7241}
}
EUVIMED